APA

Paller A. S., Seyger M. M. B., Alejandro Magariños G., Bagel J., Pinter A., Cather J., Keller S., Rodriguez Capriles C., Gontijo Lima R., Gallo G., Little C. A., Edson-Heredia E., Li L., Xu W. & Papp K. (20210514). Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS). : The British journal of dermatology.

Chicago

Paller A S, Seyger M M B, Alejandro Magariños G, Bagel J, Pinter A, Cather J, Keller S, Rodriguez Capriles C, Gontijo Lima R, Gallo G, Little C A, Edson-Heredia E, Li L, Xu W and Papp K. 20210514. Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS). : The British journal of dermatology.

Harvard

Paller A. S., Seyger M. M. B., Alejandro Magariños G., Bagel J., Pinter A., Cather J., Keller S., Rodriguez Capriles C., Gontijo Lima R., Gallo G., Little C. A., Edson-Heredia E., Li L., Xu W. and Papp K. (20210514). Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS). : The British journal of dermatology.

MLA

Paller A S, Seyger M M B, Alejandro Magariños G, Bagel J, Pinter A, Cather J, Keller S, Rodriguez Capriles C, Gontijo Lima R, Gallo G, Little C A, Edson-Heredia E, Li L, Xu W and Papp K. Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS). : The British journal of dermatology. 20210514.